172 related articles for article (PubMed ID: 32521295)
1. The association of smoking and outcomes in HPV-positive oropharyngeal cancer: A systematic review.
Chen SY; Massa S; Mazul AL; Kallogjeri D; Yaeger L; Jackson RS; Zevallos J; Pipkorn P
Am J Otolaryngol; 2020; 41(5):102592. PubMed ID: 32521295
[TBL] [Abstract][Full Text] [Related]
2. 20 pack-year smoking history as strongest smoking metric predictive of HPV-positive oropharyngeal cancer outcomes.
Chen SY; Last A; Ettyreddy A; Kallogjeri D; Wahle B; Chidambaram S; Mazul A; Thorstad W; Jackson RS; Zevallos JP; Pipkorn P
Am J Otolaryngol; 2021; 42(3):102915. PubMed ID: 33482566
[TBL] [Abstract][Full Text] [Related]
3. Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis.
Broughman JR; Xiong DD; Moeller BJ; Contrera KJ; Prendes BL; Lamarre ED; Ku JA; Burkey BB; Woody NM; Joshi NP; Adelstein DJ; Geiger JL; Frenkel CH; Milas ZL; Brickman DS; Sumrall AL; Carrizosa DR; Greskovich JF; Koyfman SA; Ward MC
Cancer; 2020 Jun; 126(12):2784-2790. PubMed ID: 32167593
[TBL] [Abstract][Full Text] [Related]
4. Systematic evaluation and meta-analysis of the prognosis of down-staging human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma using cetuximab combined with radiotherapy instead of cisplatin combined with radiotherapy.
Hu Q; Li F; Yang K
PeerJ; 2024; 12():e17391. PubMed ID: 38784388
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM
Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441
[TBL] [Abstract][Full Text] [Related]
6. Impact of Smoking on Outcomes of HPV-related Oropharyngeal Cancer Treated with Primary Radiation or Surgery.
Vawda N; Banerjee RN; Debenham BJ
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1125-1131. PubMed ID: 30513378
[TBL] [Abstract][Full Text] [Related]
7. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
[TBL] [Abstract][Full Text] [Related]
8. Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging.
Contrera KJ; Smile TD; Mahomva C; Wei W; Adelstein DJ; Broughman JR; Burkey BB; Geiger JL; Joshi NP; Ku JA; Lamarre ED; Lorenz RR; Prendes BL; Scharpf J; Schwartzman LM; Woody NM; Xiong D; Koyfman SA
Oral Oncol; 2020 Dec; 111():105030. PubMed ID: 33038751
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Smoking in Human Papillomavirus-Positive Oropharyngeal Cancer Under American Joint Committee on Cancer Eighth Edition Stage.
Chidambaram S; Nakken ER; Kennedy W; Thorstad WL; Chen SY; Pipkorn P; Zevallos JP; Mazul AL
Laryngoscope; 2020 Aug; 130(8):1961-1966. PubMed ID: 32293733
[TBL] [Abstract][Full Text] [Related]
10. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.
Platek AJ; Jayaprakash V; Merzianu M; Platek ME; Cohan DM; Hicks WL; Marimuthu SP; Winslow TB; Gupta V; Arshad H; Kuriakose MA; Dibaj S; Marshall JR; Reid ME; Warren GW; Singh AK
Laryngoscope; 2016 Dec; 126(12):2733-2738. PubMed ID: 27346612
[TBL] [Abstract][Full Text] [Related]
11. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC
BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643
[TBL] [Abstract][Full Text] [Related]
12. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
Wang MB; Liu IY; Gornbein JA; Nguyen CT
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
[TBL] [Abstract][Full Text] [Related]
13. Survival Outcomes in Human Papillomavirus-Associated Nonoropharyngeal Squamous Cell Carcinomas: A Systematic Review and Meta-analysis.
Sahovaler A; Kim MH; Mendez A; Palma D; Fung K; Yoo J; Nichols AC; MacNeil SD
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1158-1166. PubMed ID: 33057610
[TBL] [Abstract][Full Text] [Related]
14. Smoking and papillomavirus DNA in patients with p16-positive N3 oropharyngeal squamous cell carcinoma.
Gorphe P; Chekkoury Idrissi Y; Tao Y; Moya-Plana A; Casiraghi O; Janot F; Blanchard P; Mirghani H; Temam S
Head Neck; 2019 Apr; 41(4):1039-1045. PubMed ID: 30552841
[TBL] [Abstract][Full Text] [Related]
15. Impact of Smoking and Primary Tumor Subsite on Recurrence in HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Lee RH; Salesky M; Benjamin T; El-Sayed IH; George JR; Ha PK; Ryan WR; Heaton CM
Otolaryngol Head Neck Surg; 2022 Apr; 166(4):704-711. PubMed ID: 34182836
[TBL] [Abstract][Full Text] [Related]
16. Impact of Smoking on Survival Outcomes in HPV-Related Oropharyngeal Carcinoma: A Meta-analysis.
Ference R; Liao D; Gao Q; Mehta V
Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1114-1122. PubMed ID: 32452741
[TBL] [Abstract][Full Text] [Related]
17. Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Oliva M; Huang SH; Xu W; Su J; Hansen AR; Bratman SV; Ringash J; Jang R; Cho J; Bayley A; Hope AJ; Chen E; Giuliani M; Waldron J; Weinreb I; Perez-Ordonez B; Chepeha D; Kim J; O Sullivan B; Siu LL; Spreafico A
Eur J Cancer; 2019 Sep; 118():112-120. PubMed ID: 31330486
[TBL] [Abstract][Full Text] [Related]
18. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
[TBL] [Abstract][Full Text] [Related]
19. Competing mortality in oropharyngeal carcinoma according to human papillomavirus status.
Lop J; García J; López M; Taberna M; Mena M; Alemany L; Quer M; León X
Head Neck; 2019 May; 41(5):1328-1334. PubMed ID: 30549389
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of relapsed human papillomavirus-related oropharyngeal squamous cell carcinoma treated with curative intent.
Pipkorn P; Sinha P; Kallogjeri D; Adkins D; Thorstad WT; Rich JT; Jackson RS
Head Neck; 2019 May; 41(5):1312-1319. PubMed ID: 30536710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
